https://www.selleckchem.com/pr....oducts/brivudine.htm
The results represent a novel strategy for generating HSC precursors in vitro as a multipotent source of stem cells for blood disease therapies. Effective yet safe treatment of latent tuberculosis is important for preventing the spread of tuberculosis and the progression to active disease in pediatric patients. As of 2017, the short course combination regimen of weekly isoniazid and rifapentine (3HP) administered by directly observed therapy (DOT) has replaced 9 months of isoniazid as the standard of treatment for latent tuberculosis
Like
Comment
Share
